Radionuclide angiography with technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) or technetium-99m ethyl cysteinate dimer (99mTc-ECD) enables the non-invasive estimation of absolute cerebral blood flow (CBF) to be determined by using spectral analysis (SA). We previously demonstrated the clinical use of SA; however, this method involves a few manual steps. The aim of this study was to evaluate the interobserver variability of CBF estimations made using SA and compare these results with those obtained by using graphical analysis (GA). In twenty patients with various brain diseases (27–74 years old), radionuclide angiography examinations were performed using99mTc-labeled compounds (10 patients,99mTc-HMPAO; 10 patients,99mTc-ECD). Bilateral cerebral hemispheres were studied in all patients, and the brain perfusion index (BPI) values were estimated using SA and GA. The interobserver variability between two observers was then assessed. A good correlation between the BPI values assessed using both SA (BPIS) and GA (BPIG) was obtained. The correlation coefficient for BPIS (r=0.987) was almost the same as that for BPIG (r=0.982). The degree of interobserver variability was not affected by the measurement of elevated BPI values. Measurements carried out by two observers using both SA and GA exhibited a similar degree of interobserver variability. SA appears to have a satisfactory interobserver variability and may be more suitable for clinical applications.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Hellman RS, Tikofsky RS. An overview of the contributions of regional cerebral blood flow studies in cerebrovascular disease: is there a role for single photon emission computed tomography?Semin Nucl Med 1990; 20: 303–324.
Shimosegawa E, Hatazawa J, Inugami A, Fujita H, Ogawa T, Aizawa Y, et al. Cerebral infarction within six hours of onset: prediction of completed infarction.J Nucl Med 1994; 35: 1097–1103.
Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. A quantitative approach to technetium-99m hexamethyl-propylene amine oxime.Eur J Nucl Med 1992; 19: 195–200.
Matsuda H, Yagishita A, Tsuji S, Hisada K. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.Eur J Nucl Med 1995; 22: 633–637.
Murase K, Inoue T, Fujioka H, Ishimaru Y, Akamune K, Yoshimoto Y, et al. An alternative approach to estimation of the brain perfusion index for measurement of cerebral blood flow using technetium-99m compounds.Eur J Nucl Med 1999; 26: 1333–1339.
Murase K, Fujioka H, Inoue T, Ishimaru Y, Akamune A, Yamamoto Y, et al. Reproducibility of the brain perfusion index for measuring cerebral blood flow using technetium-99m compounds.Eur J Nucl Med 2001; 28: 1640–1646.
Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies.J Cereb Blood Flow Metab 1993; 13: 15–23.
Murase K, Tanada S, Inoue T, Ochi K, Fujita H, Sakaki S, et al. Measurement of the blood-brain barrier permeability of I-123 IMP, Tc-99m HMPAO and Tc-99m ECD in the human brain using compartment model analysis and dynamic SPECT [abstract].J Nucl Med 1991; 32: 911.
Di Rocco RJ, Silva DA, Kuczynski BL, Narra RK, Ramalingam K, Jurisson S, et al. The single-pass cerebral extraction and capillary permeability-surface area product of several putative cerebral blood flow imaging agents.J Nucl Med 1993; 34: 641–648.
About this article
Cite this article
Takasawa, M., Murase, K., Oku, N. et al. Interobserver variability of cerebral blood flow measurements obtained using spectral analysis and technetium-99m labeled compounds. Ann Nucl Med 17, 255–259 (2003). https://doi.org/10.1007/BF02990032
- brain perfusion index
- cerebral blood flow
- spectral analysis
- graphical analysis
- single-photon emission tomography